Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center (Massey) was founded in 1974 and received its initial NCI designation the following year. In 2023, Massey was recognized as an NCI-designated Comprehensive Cancer Center Center and subsequently changed its name to VCU Massey Comprehensive Cancer Center. Massey’s mission is to reduce the state cancer burden for all Virginians by addressing the confluence between biological, social, and policy drivers through high-impact, cutting-edge research; person-centered care across the continuum, from prevention through survivorship; community integration; and training the next generation of community-centric researchers and health care professionals. As a leading academic medical center within the Commonwealth of Virginia, Massey serves a 66-locality catchment area spanning central, southern, and eastern Virginia. This region is home to more than four million residents and is characterized by communities with substantial racial, geographic, and socioeconomic diversity that contributes to a higher overall cancer burden and significant health disparities than reported nationally.
UCSD Moores Cancer Center
As an NCI-designated Comprehensive Cancer Center, Moores Cancer Center at UC San Diego Health is among the top 4% of approximately 1,500 cancer centers in the United States, and one of only 58 Comprehensive Cancer Centers in the nation. Approximately 43,000 patients with cancer are seen at UC San Diego Health annually. Patients have access to clinical trials with a dedicated team, as well as to physicians who provide personalized care and are setting treatment standards nationwide for more than 200 types of cancer. According to the 2025-2026 U.S. News & World Report “Best Hospitals” survey, the UC San Diego Health cancer program was ranked 42nd in the nation.
The Cancer Epitope Database and Analysis Resource (CEDAR)
The Cancer Epitope Database and Analysis Resource (CEDAR – cedar.iedb.org) is a freely available resource funded by NCI. It catalogs experimental data on antibody and T cell epitopes studied in humans in the context of cancer disease. CEDAR also hosts tools to assist in the prediction and analysis of cancer epitopes. CEDAR is a companion site to the Immune Epitope Database (IEDB – iedb.org), which is funded by NIAID, and houses epitope data on infectious disease, allergy, autoimmunity and transplantation.
St. Jude Children’s Research Hospital
St. Jude Children’s Research Hospital is a National Cancer Institute (NCI)–designated Comprehensive Cancer Center devoted solely to children. Our 300 faculty work across the spectrum of basic, translational, clinical, and population science in a highly collaborative multidisciplinary environment that includes a Nobel laureate and members of the National Academy of Science and the National Academy of Medicine. St. Jude is ranked on Fortune Magazine’s “Best Workplaces in Health Care & Biopharma” and Glassdoor’s “Best Places to Work,” and is located in the heart of Memphis, Tennessee, a vibrant and friendly city at the historic American crossroads of music, trade, food and culture. At St. Jude, we have one common goal: find cures for children with cancer and other life-threatening diseases through research and treatment. As both a world-class research institute and a specialized children’s hospital, St. Jude provides an unparalleled opportunity to advance your scientific training and launch your career. | St. Jude Children’s Research Hospital is a global leader in the research and treatment of pediatric cancer and other life-threatening diseases of childhood. Headquartered in Memphis, Tennessee, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude has been named a top pediatric cancer hospital on U.S. News & World Report’s annual “Best Hospitals” list and named to Fortune magazine’s “100 Best Companies to Work For” list. Research and treatments developed at St. Jude are shared to help improve the survival rate for children with cancer and other life-threatening diseases worldwide. St. Jude is recognized as one of the world’s premier pediatric research and treatment institutions with a focus on acute lymphoblastic leukemia, brain tumors and infectious diseases. With eight affiliate clinics across the country, St. Jude treats about 8,600 children each year. Beyond the United States, the institution’s St. Jude Global initiative seeks to improve health care for children with life-threatening disease worldwide. The goal of the Department of Infectious Diseases at St. Jude Children’s Research Hospital is to study devastating diseases of childhood through a comprehensive approach including basic science research, translational trials, and bedside care. Among the top infectious causes of death worldwide are respiratory diseases and HIV/AIDS. The Department of Infectious Diseases seeks to focus on the pathogenesis of these infections with a breadth of commitment that extends from the research bench to the bedside. Investigations take place at progressive levels: manipulation of genes is expected to lead to phenotypes in cell culture systems that can be modeled in animal studies. Therapeutic candidates in the form of antimicrobials, vaccines, or adjunctive therapies are further pursued in clinical trials in children. Follow us to discover the research, scientific discoveries, clinical care and employment opportunities at St. Jude. View our career opportunities: www.stjude.org/JoinOurMission. Follow St. Jude across social media at @stjuderesearch.
Southern Research – Birmingham, AL
Southern Research is a nonprofit, full-service contract research organization with 80+ years of experience in drug discovery and development. Our team of industry-leading experts provide personalized, white-glove support to our clients—including insightful project management, exceptional quality assurance, regulatory affairs guidance, and collaborative problem solving. With ABSL-2 and ABSL-3 containment, our laboratories are also equipped for studies involving pathogenic agents. Southern Research offers competitive timelines to advance your program efficiently and effectively. We look forward to helping your company move science and build better health outcomes for all.
Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC is a 501(c)(3) not-for-profit organization.
Science/AAAS
Since 1848, AAAS and its members have worked together to advance science and serve society. As part of these efforts, AAAS publishes Science, a multidisciplinary peer-reviewed journal, Science Advances, an open-access online journal, Science Immunology, Science Robotics, Science Signaling, and Science Translational Medicine. AAAS also offers programs focused on science policy, international cooperation, science education, diversity, and career development for scientists.
Say YES to Hope
Say YES to Hope is changing the world for those who are diagnosed with advanced cancer through outreach, education, support, and hope. We are committed to serving this underserved population of cancer patients because the association between access to care and support demonstrates increased survival, better outcomes, and improved quality of life. Our revolutionary campaigns in outreach and education help people live more fully in spite of advanced cancer and dramatically enhances the outlook for living with this life limiting diagnosis.
San Antonio Breast Cancer Symposium
The San Antonio Breast Cancer Symposium® (SABCS) is the largest breast cancer symposium in the world, dedicated to advancing research, treatment, and patient care. Held annually at the Henry B. Gonzalez Convention Center, SABCS brings together more than 11,000 clinicians, researchers, and industry professionals from over 100 countries. Renowned for its high-impact scientific program, the Symposium features late-breaking research, educational sessions, and multidisciplinary collaboration that influence clinical practice worldwide. For exhibitors, SABCS offers a highly targeted environment to connect with key decision-makers, showcase innovations, and build strategic partnerships. The integrated exhibit hall—featuring poster sessions, networking spaces, and educational opportunities—drives strong attendee engagement and consistent traffic, maximizing visibility and meaningful interactions.